Skip to content

Clinical trials

Observational Neoplasm Metastasis trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Observational Country / region: Netherlands Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20062
20071
20111
20141
20152
20171
20192
20201
20213
20222
20231
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Unknown status6
Recruiting4
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Maastricht University Medical Center3
Maastricht Radiation Oncology2
National Cancer Institute (NCI)2
UMC Utrecht2
AO Innovation Translation Center1
Academisch Ziekenhuis Maastricht1
Amsterdam UMC, location VUmc1
Cardiovascular and Interventional Radiological Society of Europe1
Centre Leon Berard1
Elisabeth-TweeSteden Ziekenhuis1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis22
Recurrence5
Neoplasms4
Brain Neoplasms2
Breast Neoplasms2
Carcinoma, Hepatocellular2
Carcinoma, Squamous Cell2
Lung Neoplasms2
Prostatic Neoplasms2
Adenoma, Islet Cell1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.